Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Raloxifene prevents skeletal fragility in adult female Zucker Diabetic Sprague-Dawley rats.

Hill Gallant KM, Gallant MA, Brown DM, Sato AY, Williams JN, Burr DB.

PLoS One. 2014 Sep 22;9(9):e108262. doi: 10.1371/journal.pone.0108262. eCollection 2014.

2.

Bone cell-independent benefits of raloxifene on the skeleton: a novel mechanism for improving bone material properties.

Gallant MA, Brown DM, Hammond M, Wallace JM, Du J, Deymier-Black AC, Almer JD, Stock SR, Allen MR, Burr DB.

Bone. 2014 Apr;61:191-200. doi: 10.1016/j.bone.2014.01.009. Epub 2014 Jan 24.

3.

Multiscale analysis of morphology and mechanics in tail tendon from the ZDSD rat model of type 2 diabetes.

Gonzalez AD, Gallant MA, Burr DB, Wallace JM.

J Biomech. 2014 Feb 7;47(3):681-6. doi: 10.1016/j.jbiomech.2013.11.045. Epub 2013 Dec 6.

4.

Nanoscale changes in collagen are reflected in physical and mechanical properties of bone at the microscale in diabetic rats.

Hammond MA, Gallant MA, Burr DB, Wallace JM.

Bone. 2014 Mar;60:26-32. doi: 10.1016/j.bone.2013.11.015. Epub 2013 Nov 21.

5.

A novel approach to evaluate the effect of medicaments used in endodontic regeneration on root canal surface indentation.

Yassen GH, Chu TM, Gallant MA, Allen MR, Vail MM, Murray PE, Platt JA.

Clin Oral Investig. 2014 Jul;18(6):1569-75. doi: 10.1007/s00784-013-1125-x. Epub 2013 Oct 8. Erratum in: Clin Oral Investig. 2014 Jul;18(6):1577.

PMID:
24100639
6.

In vivo reference point indentation reveals positive effects of raloxifene on mechanical properties following 6 months of treatment in skeletally mature beagle dogs.

Aref M, Gallant MA, Organ JM, Wallace JM, Newman CL, Burr DB, Brown DM, Allen MR.

Bone. 2013 Oct;56(2):449-53. doi: 10.1016/j.bone.2013.07.009. Epub 2013 Jul 17.

7.

Elevated mechanical loading when young provides lifelong benefits to cortical bone properties in female rats independent of a surgically induced menopause.

Warden SJ, Galley MR, Hurd AL, Wallace JM, Gallant MA, Richard JS, George LA.

Endocrinology. 2013 Sep;154(9):3178-87. doi: 10.1210/en.2013-1227. Epub 2013 Jun 19.

8.

Inverse agonist and pharmacochaperone properties of MK-0524 on the prostanoid DP1 receptor.

Labrecque P, Roy SJ, Fréchette L, Iorio-Morin C, Gallant MA, Parent JL.

PLoS One. 2013 Jun 10;8(6):e65767. doi: 10.1371/journal.pone.0065767. Print 2013.

9.

Reference-point indentation correlates with bone toughness assessed using whole-bone traditional mechanical testing.

Gallant MA, Brown DM, Organ JM, Allen MR, Burr DB.

Bone. 2013 Mar;53(1):301-5. doi: 10.1016/j.bone.2012.12.015. Epub 2012 Dec 27.

10.

Bone remodelling in osteoarthritis.

Burr DB, Gallant MA.

Nat Rev Rheumatol. 2012 Nov;8(11):665-73. doi: 10.1038/nrrheum.2012.130. Epub 2012 Aug 7. Review.

PMID:
22868925
11.

Bisphosphonate binding affinity affects drug distribution in both intracortical and trabecular bone of rabbits.

Turek J, Ebetino FH, Lundy MW, Sun S, Kashemirov BA, McKenna CE, Gallant MA, Plotkin LI, Bellido T, Duan X, Triffitt JT, Russell RG, Burr DB, Allen MR.

Calcif Tissue Int. 2012 Mar;90(3):202-10. doi: 10.1007/s00223-012-9570-0. Epub 2012 Jan 17.

PMID:
22249525
12.

Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway.

Matzelle MM, Gallant MA, Condon KW, Walsh NC, Manning CA, Stein GS, Lian JB, Burr DB, Gravallese EM.

Arthritis Rheum. 2012 May;64(5):1540-50. doi: 10.1002/art.33504.

13.

An interaction between L-prostaglandin D synthase and arrestin increases PGD2 production.

Mathurin K, Gallant MA, Germain P, Allard-Chamard H, Brisson J, Iorio-Morin C, de Brum Fernandes A, Caron MG, Laporte SA, Parent JL.

J Biol Chem. 2011 Jan 28;286(4):2696-706. doi: 10.1074/jbc.M110.178277. Epub 2010 Nov 26.

14.

ANKRD13C acts as a molecular chaperone for G protein-coupled receptors.

Parent A, Roy SJ, Iorio-Morin C, Lépine MC, Labrecque P, Gallant MA, Slipetz D, Parent JL.

J Biol Chem. 2010 Dec 24;285(52):40838-51. doi: 10.1074/jbc.M110.142257. Epub 2010 Oct 19.

15.

Increased concentrations of prostaglandin D2 during post-fracture bone remodeling.

Gallant MA, Chamoux E, Bisson M, Wolsen C, Parent JL, Roux S, de Brum-Fernandes AJ.

J Rheumatol. 2010 Mar;37(3):644-9. doi: 10.3899/jrheum.090622. Epub 2010 Jan 15.

PMID:
20080921
16.

Characterization of C-terminal tail determinants involved in CRTH2 receptor trafficking: identification of a recycling motif.

Roy SJ, Parent A, Gallant MA, de Brum-Fernandes AJ, Stanková J, Parent JL.

Eur J Pharmacol. 2010 Mar 25;630(1-3):10-8. doi: 10.1016/j.ejphar.2009.12.022. Epub 2009 Dec 24.

PMID:
20035740
17.

Prostaglandin D2 receptors control osteoclastogenesis and the activity of human osteoclasts.

Durand M, Gallant MA, de Brum-Fernandes AJ.

J Bone Miner Res. 2008 Jul;23(7):1097-105. doi: 10.1359/jbmr.080228.

18.

Differential regulation of the signaling and trafficking of the two prostaglandin D2 receptors, prostanoid DP receptor and CRTH2.

Gallant MA, Slipetz D, Hamelin E, Rochdi MD, Talbot S, de Brum-Fernandes AJ, Parent JL.

Eur J Pharmacol. 2007 Feb 28;557(2-3):115-23. Epub 2006 Dec 5.

PMID:
17207480
19.

Prostaglandin production by human osteoclasts in culture.

Hackett JA, Allard-Chamard H, Sarrazin P, de Fatima Lucena M, Gallant MA, Fortier I, Nader M, Parent JL, Bkaily G, de Brum-Fernandes AJ.

J Rheumatol. 2006 Jul;33(7):1320-8. Epub 2006 Jun 1.

PMID:
16758505
20.

Implication of prostaglandin receptors in the accumulation of osteoprotegerin in human osteoblast cultures.

Samadfam R, Gallant MA, Miousse MC, Parent JL, de Brum-Fernandes AJ.

J Rheumatol. 2006 Jun;33(6):1167-75.

PMID:
16755666
21.

Oligomerization of the alpha and beta isoforms of the thromboxane A2 receptor: relevance to receptor signaling and endocytosis.

Laroche G, Lépine MC, Thériault C, Giguère P, Giguère V, Gallant MA, de Brum-Fernandes A, Parent JL.

Cell Signal. 2005 Nov;17(11):1373-83.

PMID:
15893915
22.

Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors.

Gallant MA, Samadfam R, Hackett JA, Antoniou J, Parent JL, de Brum-Fernandes AJ.

J Bone Miner Res. 2005 Apr;20(4):672-81. Epub 2004 Dec 6.

23.

Role of EP3 and EP4 prostaglandin receptors in reorganization of the cytoskeleton in mature human osteoclasts.

Sarrazin P, Hackett JA, Fortier I, Gallant MA, de Brum-Fernandes A.

J Rheumatol. 2004 Aug;31(8):1598-606.

PMID:
15290741
24.

Role of extracellular cysteine residues in dimerization/oligomerization of the human prostacyclin receptor.

Giguère V, Gallant MA, de Brum-Fernandes AJ, Parent JL.

Eur J Pharmacol. 2004 Jun 21;494(1):11-22.

PMID:
15194446
25.

Immunolocalization of the prostaglandin E2 receptor subtypes in human bone tissue: differences in foetal, adult normal, osteoporotic and pagetic bone.

Fortier I, Gallant MA, Hackett JA, Patry C, de Brum-Fernandes AJ.

Prostaglandins Leukot Essent Fatty Acids. 2004 May;70(5):431-9.

PMID:
15062845

Supplemental Content

Loading ...
Support Center